Please use this identifier to cite or link to this item:
https://observatorio.fm.usp.br/handle/OPI/35855
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | |
dc.contributor.author | PONS-ESTEL, Guillermo J. | |
dc.contributor.author | UGARTE-GIL, Manuel Francisco | |
dc.contributor.author | HARVEY, Guillermina B. | |
dc.contributor.author | WOJDYLA, Daniel | |
dc.contributor.author | QUINTANA, Rosana | |
dc.contributor.author | SAURIT, Veronica | |
dc.contributor.author | SORIANO, Enrique R. | |
dc.contributor.author | BONFA, Eloisa | |
dc.contributor.author | MASSARDO, Loreto | |
dc.contributor.author | CARDIEL, Mario | |
dc.contributor.author | VILA, Luis M. | |
dc.contributor.author | GRIFFIN, Russell | |
dc.contributor.author | PONS-ESTEL, Bernardo A. | |
dc.contributor.author | ALARCON, Graciela S. | |
dc.date.accessioned | 2020-06-01T14:46:43Z | - |
dc.date.available | 2020-06-01T14:46:43Z | - |
dc.date.issued | 2020 | |
dc.identifier.citation | RMD OPEN, v.6, n.1, article ID UNSP e001097, 6p, 2020 | |
dc.identifier.issn | 2056-5933 | |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/35855 | - |
dc.description.abstract | Objective To evaluate the performance of the 2019 European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) systemic lupus erythematosus (SLE) criteria in terms of earlier patients' classification in comparison to the 1982/1997 ACR or the 2012 Systemic Lupus International Collaborating Clinics (SLICC) criteria. Materials and methods Patients from a Latin America, multiethnic, multicentre cohort, where SLE was defined using the physicians' diagnosis, were included. To calculate the sensitivity of the 2019 EULAR/ACR criteria, the 1982/1997 ACR criteria were considered the gold standard. Additionally, comparison of the 1982/1997 ACR criteria and the 2012 SLICC criteria with the 2019 EULAR/ACR criteria was performed. Results The sensitivity of the 2019 EULAR/ACR criteria when compared with the 1982/1997 ACR criteria as the gold standard was 91.3%. This new set of criteria allowed an earlier SLE patient classification in 7.4% (mean 0.67 years) and 0.6% (mean 1.47 years) than the 1982/1997 ACR and the 2012 SLICC criteria, respectively. Patients accruing the 2019 EULAR/ACR earlier than the 1982/1997 ACR criteria were more likely to have high anti-dsDNA titres; those accruing them later were less likely to have mucocutaneous and joint manifestations; this was not observed when comparing them with the 2012 SLICC criteria. Conclusions The 2019 EULAR/ACR criteria classified earlier only a small proportion of Latin America patients than with the two other criteria sets in real-life clinical practice scenarios. Further studies in different patient populations are needed before these new criteria are adopted worldwide. | eng |
dc.language.iso | eng | |
dc.publisher | BMJ PUBLISHING GROUP | eng |
dc.relation.ispartof | Rmd Open | |
dc.rights | openAccess | eng |
dc.subject.other | revised criteria | eng |
dc.subject.other | classification | eng |
dc.subject.other | erythematosus | eng |
dc.title | Applying the 2019 EULAR/ACR lupus criteria to patients from an established cohort: a Latin American perspective | eng |
dc.type | article | eng |
dc.rights.holder | Copyright BMJ PUBLISHING GROUP | eng |
dc.contributor.groupauthor | GLADEL | |
dc.identifier.doi | 10.1136/rmdopen-2019-001097 | |
dc.identifier.pmid | 31958284 | |
dc.subject.wos | Rheumatology | eng |
dc.type.category | original article | eng |
dc.type.version | publishedVersion | eng |
hcfmusp.author.external | PONS-ESTEL, Guillermo J.:Ctr Reg Enfermedades Autoinmunes & Reumat GO CREA, Rosario, Santa Fe, Argentina; Hosp Prov Rosario, Serv Reumatol, Rosario, Santa Fe, Argentina | |
hcfmusp.author.external | UGARTE-GIL, Manuel Francisco:Univ Cient Sur, Sch Med, Lima, Peru; Hosp Nacl Guillermo Almenara Irigoyen, Serv Reumatol, EsSalud, Lima, Peru | |
hcfmusp.author.external | HARVEY, Guillermina B.:Univ Nacl Rosario, Fac Ciencias Econ & Estadist, Escuela Estadist, Rosario, Argentina | |
hcfmusp.author.external | WOJDYLA, Daniel:Univ Nacl Rosario, Fac Ciencias Econ & Estadist, Escuela Estadist, Rosario, Argentina | |
hcfmusp.author.external | QUINTANA, Rosana:Ctr Reg Enfermedades Autoinmunes & Reumat GO CREA, Rosario, Santa Fe, Argentina; Hosp Prov Rosario, Serv Reumatol, Rosario, Santa Fe, Argentina | |
hcfmusp.author.external | SAURIT, Veronica:Hosp Privado Univ Cordoba, Serv Reumatol, Cordoba, Argentina | |
hcfmusp.author.external | SORIANO, Enrique R.:Hosp Italiano Buenos Aires, Rheumatol, Buenos Aires, DF, Argentina | |
hcfmusp.author.external | MASSARDO, Loreto:Univ San Sebastian, Ctr Biol Celular & Biomed, Santiago, Chile | |
hcfmusp.author.external | CARDIEL, Mario:Ctr Invest Clin Morelia, Morelia, Michoacan, Mexico | |
hcfmusp.author.external | VILA, Luis M.:Univ Puerto Rico, Div Rheumatol, San Juan, PR 00936 USA | |
hcfmusp.author.external | GRIFFIN, Russell:Univ Alabama Birmingham, Epidemiol, Birmingham, AL USA | |
hcfmusp.author.external | PONS-ESTEL, Bernardo A.:Ctr Reg Enfermedades Autoinmunes & Reumat GO CREA, Rosario, Santa Fe, Argentina | |
hcfmusp.author.external | ALARCON, Graciela S.:Univ Alabama Birmingham, Dept Med, Div Clin Immunol & Rheumatol, Sch Med, Birmingham, AL 35294 USA | |
hcfmusp.description.articlenumber | UNSP e001097 | |
hcfmusp.description.issue | 1 | |
hcfmusp.description.volume | 6 | |
hcfmusp.origem | WOS | |
hcfmusp.origem.id | WOS:000527753900018 | |
hcfmusp.origem.id | 2-s2.0-85078515209 | |
hcfmusp.publisher.city | LONDON | eng |
hcfmusp.publisher.country | ENGLAND | eng |
hcfmusp.relation.reference | Agmon-Levin N, 2012, AUTOIMMUN REV, V11, P593, DOI 10.1016/j.autrev.2011.10.020 | eng |
hcfmusp.relation.reference | Alarcon-Riquelme ME, 2019, CURR RHEUMATOL REP, V21, DOI 10.1007/s11926-019-0810-4 | eng |
hcfmusp.relation.reference | Aringer M, 2019, ANN RHEUM DIS, V78, P1151, DOI 10.1136/annrheumdis-2018-214819 | eng |
hcfmusp.relation.reference | Aringer M, 2019, ARTHRITIS RHEUMATOL, V71, P1400, DOI 10.1002/art.40930 | eng |
hcfmusp.relation.reference | Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928 | eng |
hcfmusp.relation.reference | Johnson SR, 2019, J RHEUMATOL, V46, P721, DOI 10.3899/jrheum.180478 | eng |
hcfmusp.relation.reference | Petri M, 2012, ARTHRITIS RHEUM-US, V64, P2677, DOI 10.1002/art.34473 | eng |
hcfmusp.relation.reference | Pons-Estel BA, 2004, MEDICINE, V83, P1, DOI 10.1097/01.md.0000104742.42401.e2 | eng |
hcfmusp.relation.reference | Pons-Estel GJ, 2015, LUPUS, V24, P536, DOI 10.1177/0961203314567753 | eng |
hcfmusp.relation.reference | Schmajuk G, 2018, ARTHRIT CARE RES, V70, P1488, DOI 10.1002/acr.23503 | eng |
hcfmusp.relation.reference | TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101 | eng |
hcfmusp.relation.reference | Tedeschi SK, 2019, ANN RHEUM DIS, V78, P634, DOI 10.1136/annrheumdis-2018-214685 | eng |
hcfmusp.relation.reference | Tedeschi SK, 2018, ARTHRIT CARE RES, V70, P571, DOI 10.1002/acr.23317 | eng |
hcfmusp.relation.reference | Teruel M, 2017, RHEUMATOLOGY, V56, P78, DOI 10.1093/rheumatology/kew339 | eng |
dc.description.index | MEDLINE | eng |
hcfmusp.citation.scopus | 25 | - |
hcfmusp.scopus.lastupdate | 2024-03-29 | - |
Appears in Collections: | Artigos e Materiais de Revistas Científicas - FM/MCM Artigos e Materiais de Revistas Científicas - HC/ICHC Artigos e Materiais de Revistas Científicas - LIM/17 |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
art_PONS-ESTEL_Applying_the_2019_EULARACR_lupus_criteria_to_patients_2020.PDF | publishedVersion (English) | 327.87 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.